Core & Main (CNM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
22 Jan, 2026Executive summary
Net sales reached a record $1.96 billion for Q2 2024, up 6% year-over-year, driven by acquisitions despite project delays and softer end-market volumes.
Adjusted EBITDA declined 5% to $257 million, with margin down 140 basis points to 13.1%, impacted by higher SG&A and interest expenses.
Diluted EPS fell 8% to $0.61, with net income down 23.2% to $126 million, primarily due to lower operating income and higher interest expense.
Five acquisitions completed or announced, including entry into the Canadian market via HM Pipe Products, expanding product and geographic reach.
Leadership changes and organizational realignment were implemented to support growth and integration of new acquisitions.
Financial highlights
Q2 2024 net sales: $1.96 billion (+6% year-over-year); gross profit: $518 million (+3% year-over-year); gross margin: 26.4% (down 50 bps year-over-year).
Net income: $126 million for Q2 2024 (down 23.2% year-over-year); diluted EPS: $0.61 (down 8%).
Adjusted EBITDA: $257 million for Q2 2024 (down 5% year-over-year); margin: 13.1% (down 140 bps year-over-year).
SG&A expenses rose 13% to $268 million, mainly from acquisitions; SG&A as % of sales increased to 13.6%.
Net cash from operating activities was $48 million for Q2 and $126 million year-to-date, reflecting higher working capital investment.
Outlook and guidance
FY2024 net sales guidance lowered to $7.3–$7.4 billion and Adjusted EBITDA to $900–$930 million due to weather disruptions and delayed growth.
Operating cash flow conversion guidance raised to 65–75% of Adjusted EBITDA.
End markets expected to be flat to slightly down for the year, with some growth deferred to 2025.
M&A expected to contribute 8–9% of total sales growth for the year.
Management remains optimistic on long-term demand despite near-term market softness.
Latest events from Core & Main
- Net sales up 11% to $1.74B, but margins narrowed and net income declined on higher costs.CNM
Q1 202531 Jan 2026 - Record Q3 sales, raised outlook, and strong cash flow highlight robust growth and execution.CNM
Q3 202512 Jan 2026 - Record sales and EBITDA in FY24; 2025 outlook strong with growth and stable margins.CNM
Q4 202526 Dec 2025 - Q3 net sales and profit rose, with margin expansion and increased share repurchases.CNM
Q3 202610 Dec 2025 - Record sales, new leadership, and strong governance mark this year's proxy highlights.CNM
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, all board-backed.CNM
Proxy Filing1 Dec 2025 - Record Q1 sales up 9.8%–10%, margin gains, and FY2025 outlook reaffirmed.CNM
Q1 202610 Nov 2025 - Q2 sales rose 6.6%–7% with strong municipal demand, but 2025 guidance was lowered on higher costs.CNM
Q2 202610 Sep 2025